ANTX - AN2 Therapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
AN2 Therapeutics, Inc.
IPO Date: March 25, 2022
Sector: Healthcare
Industry: Biotech
Market Cap: $183.02M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.35 | 4.58%
Avg Daily Range (30 D): $0.19 | 3.52%
Avg Daily Range (90 D): $0.18 | 3.55%
Institutional Daily Volume
Avg Daily Volume: .24M
Avg Daily Volume (30 D): .22M
Avg Daily Volume (90 D): .2M
Trade Size
Avg Trade Size (Sh.): 168
Avg Trade Size (Sh.) (30 D): 77
Avg Trade Size (Sh.) (90 D): 75
Institutional Trades
Total Institutional Trades: 61
Avg Institutional Trade: $1.87M
Avg Institutional Trade (30 D): $1.33M
Avg Institutional Trade (90 D): $2.93M
Avg Institutional Trade Volume: .41M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.77M
Avg Closing Trade (30 D): $1.33M
Avg Closing Trade (90 D): $3.83M
Avg Closing Volume: 346.91K
 
News
Aug 31, 2026 @ 5:00 PM
Nontuberculous Mycobacterial Infections Market to ...
Source: Delveinsight
May 21, 2024 @ 1:35 PM
Down -5.51% in 4 Weeks, Here's Why AN2 Therapeutic...
Source: Zacks Equity Research
Feb 13, 2024 @ 1:08 PM
ZoomInfo Technologies To Rally Around 50%? Here Ar...
Source: Avi Kapoor
Feb 12, 2024 @ 7:15 PM
Nasdaq Edges Lower; ContextLogic Shares Surge
Source: Avi Kapoor
Feb 12, 2024 @ 6:07 PM
Why Big Lots Shares Are Trading Lower By Around 31...
Source: Avi Kapoor
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.18 $-.29
Diluted EPS $-.18 $-.29
Revenue $M $M
Gross Profit
Net Income / Loss $-8.19M $-10.03M
Operating Income / Loss $-8.9M $-10.55M
Cost of Revenue
Net Cash Flow $-9.17M $33.55M
PE Ratio